Navigation Links
phaseUp™ Life Sciences Firm Delivers Innovative Methodologies to Build High Performing Clinical Development Teams and Leadership for Outsourcing Success

Today marked the official launch of phaseUP™, a new life sciences leadership firm that is enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, and broader project team alignment.

Founded by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in the intricacies of drug development and team development in both the commercial and operational aspects of the global life sciences industry.

Brenda Reese has a 20+ year track record for creating consistent and meaningful improvements in employee and team engagement, operational productivity, and financial performance in the CRO, pharma and biotech sectors. Click here for more information on Reese.

“We need a complete overhaul in how our industry is outsourcing and forming clinical development teams,” Reese explained. “Project teams must take the time to establish a solid foundation up front if they have any hope of a successful clinical program. phaseUP™ methodologies build cohesive teams and leaders who are connected, engaged, and committed to achieving team and broader organizational goals. Click here to watch a 2-minute video of Reese discussing one of the greatest challenges facing the life sciences industry.

phaseUP™ Methodologies – Building High Performing Teams and Leaders

Creating a foundation of trust, respect, a shared vision and commitment with the broader team is critical to the success of any clinical program. phaseUP™’s exclusive methodologies spark growth in leaders and foster team alignment by elevating insights, fostering inspiration and camaraderie. Clients can take advantage of phaseUP™ services together, or as individual modules…

  • First90Days™ – The exclusive phaseUP™ First90Days™ program works with pharma/biotech teams and their outsourcing partners for the critical first 90 days of a clinical development program. First90Days™ cultivates a collaborative environment that sets up the team for success in even the most challenging circumstances to meet deliverables, reduce costs and improve engagement, satisfaction and retention.
  • Team Development – phaseUP™ engages every team member and elicits the commitment to achieve the client team’s potential – all within the context of the challenges facing the project, the team and each person’s individual role. phaseUP™ also offers team remediation.
  • Leadership/Executive Coaching – phaseUP™ provides a confidential sounding board for clients. Coaches work closely with clients’ executive leadership to identify strengths and areas for growth to optimize their performance and leadership. The result: higher motivation levels, more effective leadership, employee satisfaction and retention, and more flexible approaches to problem-solving and seizing opportunities.

About phaseUP™
phaseUP™ is a life sciences leadership development firm focused on igniting growth in leaders and cultivating alignment in teams, with an emphasis on clinical development teams. Our experienced team of coaches helps leaders, staff and teams achieve their professional, personal and organizational goals through the exclusive phaseUP™ system of elevating insight, identifying solutions and ongoing support. Visit for more information.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. Lockheed Martin to Continue Providing Life Sciences Support to NASA
2. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
3. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
4. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
5. A “Fail Fast” Strategy for Lead Optimization Pharmacology and Toxicology, New Xtalks Life Sciences Webinar
6. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
7. RoviSys Partners with POMS MES to Expand Life Sciences Capabilities
8. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
9. Digital Science & SciBite Join Forces to Harness Big Data for Life Sciences
10. NuView Life Sciences and Thomas Jefferson University Sign Agreement for Exclusive Development and Commercialization Rights to Novel Prostate Cancer Diagnostic
11. CfPIE Announces Advisory Board to Support Continued Life Sciences Training Alignment with Industry Regulations
Post Your Comments:
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):